-
公开(公告)号:CA2038589A1
公开(公告)日:1991-09-21
申请号:CA2038589
申请日:1991-03-19
Applicant: HOECHST AG
Inventor: JAHNE GERHARD , ROESNER MANFRED , WINKLER IRVIN , HELSBERG MATTHIAS , SCHOLL THOMAS
IPC: A61K31/52 , A61K31/522 , A61P31/12 , A61P31/22 , C07D473/00 , C07D473/04 , C07D473/16 , C07D473/18 , C07D473/20 , C07D473/22 , C07D473/24 , C07D473/28 , C07D473/32 , C07D473/34 , C07D473/36 , C07D473/40 , C07F9/547 , A61K31/675
Abstract: 1 HOE 90/F 093 of the disclosure: Substituted purines, processes for their preparation and their use as antiviral agents Compounds of the formula I (I) in which the substituents R1 to R5 have the said meanings, have antiviral activity.
-
22.
公开(公告)号:AU7016491A
公开(公告)日:1991-08-08
申请号:AU7016491
申请日:1991-02-01
Applicant: HOECHST AG
Inventor: PEYMAN ANUSCHIRWAN , UHLMANN EUGEN , BUDT KARLHEINZ , KNOLLE JOCHEN , WINKLER IRVIN , HELSBERG MATTHIAS
IPC: A61K31/66 , A61P31/12 , C07F9/38 , C07F9/40 , C07F9/6574
Abstract: The use of a compound of the formula I I in which V is an alkyl group, fluorine, chlorine, bromine, or iodine, n is an integer from 1 to 5, W is an alkyl, alkenyl, alkynyl or alkoxy group, cyanide, nitro, carboxyl, hydrogen or a cycloalkyl, aryl, aralkyl or carboalkoxy group, R1 and R2 are an alkyl, alkenyl, alkynyl, cycloalkyl or halogenoalkyl group, sodium, potassium, calcium, magnesium, aluminum, lithium, ammonium, triethylammonium or hydrogen, R1 and R2 together form a cyclic diester, R3 and R4 are an alkyl, alkenyl, alkynyl, carboalkoxy, cycloalkyl or alkoxy group, hydrogen, fluorine, chlorine, bromine or iodine and X, Y and Z are oxygen or sulfur, for the treatment of diseases caused by DNA viruses or RNA viruses is described.
-
公开(公告)号:HUT52957A
公开(公告)日:1990-09-28
申请号:HU404888
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , WINKLER IRVIN , MEICHSNER CHRISTOPH , HELSBERG MATTHIAS
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00
Abstract: The preparation contains or consists of… a) at least one sulphated polysaccharide and… b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
-
公开(公告)号:ZA8905176B
公开(公告)日:1990-03-28
申请号:ZA8905176
申请日:1989-07-07
Applicant: HOECHST AG
Inventor: KLOSA JOSEF , JOSEF KLOSA , KROEGER HANS , HANS KROEGER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHRINNER ELMAR , ELMAR SCHRINNER
IPC: A61K31/52 , A61P31/12 , C07D473/38 , C07D
CPC classification number: C07D473/38
-
公开(公告)号:ZA8805577B
公开(公告)日:1989-04-26
申请号:ZA8805577
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , ELMAR SCHRINNER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K , C07D , C08B
CPC classification number: A61K31/715 , A61K31/52
-
公开(公告)号:NO883375A
公开(公告)日:1989-02-02
申请号:NO883375
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SHRINNER ELMAR , WINKLER IRVIN , MEICHSNER CHRISTOPH , HELSBERG MATTHIAS
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K
CPC classification number: A61K31/715 , A61K31/52
-
公开(公告)号:NO883375D0
公开(公告)日:1988-07-29
申请号:NO883375
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SHRINNER ELMAR , WINKLER IRVIN , MEICHSNER CHRISTOPH , HELSBERG MATTHIAS
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K
Abstract: The preparation contains or consists of… a) at least one sulphated polysaccharide and… b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
-
公开(公告)号:CA2132265C
公开(公告)日:2007-08-07
申请号:CA2132265
申请日:1994-09-16
Applicant: HOECHST AG
Inventor: PEYMAN ANUSCHIRWAN , UHLMANN EUGEN , MAG MATTHIAS , KRETZSCHMAR GERHARD , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: C07H21/04 , C12N15/09 , A61K31/70 , A61K31/7088 , A61K47/48 , A61K48/00 , A61P31/12 , A61P31/22 , C07H21/00 , C12N15/113
Abstract: The invention relates to novel antisense oligonucleotides having the sequences AO1 (Herp099): 5'-G C G G G G C T C C A T G G G G G T C G-3' AO2 (Herp018): 5'-G C A G G A G G A T G C T G A C O A G G-3' AO3 (Herp002): 5'-G G G G C G G G G C T C C A T G G G G G-3' AO4 (Herp112): 5'-G G C G G G G C T C C A T G G G G G T C-3' AO5 (Herp034): 5'-G G G G C T C C A T G G G G G T C G T A-3' AO6 (Herp024): 5'-A A G A G G T C C A T T G G G T G G G G-3' or AO7 (Herp028): 5'-G G C C C T G C T G T T C C G T G G C G-3' and their mixtures, homologs or modified forms, against HSV 1.
-
公开(公告)号:FI115215B
公开(公告)日:2005-03-31
申请号:FI930221
申请日:1993-01-20
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERARD JOSEPH , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R = H, a substituent or -P(=W)ZZ'; R = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R , R = substituents; p = 1-100; q = 0-18; R = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta or a group of formula (ii); alpha = 1-11; beta = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha or beta configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR R ); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R , R = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
-
公开(公告)号:FI115214B
公开(公告)日:2005-03-31
申请号:FI930220
申请日:1993-01-20
Applicant: HOECHST AG
Inventor: UHLMANN EUGEN , PEYMAN ANUSCHIRWAN , O'MALLEY GERARD JOSEPH , HELSBERG MATTHIAS , WINKLER IRVIN
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07H1/00 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: The invention relates to compounds of the formula I in which R is H, alkyl, acyl, aryl or a phosphate residue; R is H, OH, alkoxy, NH2 or halogen; B is a base customary in nucleotide chemistry; a is O or CH2; n is an integer from 1 to 100; W is O, S or Se; V is O, S or NH; Y is O, S, NH or CH2; Y' is O, S, NH or alkylene; X is OH or SH; U is OH, SH, SeH, alkyl, aryl or amine, and Z is OH, SH, SeH, an optionally substituted radical from the series comprising alkyl, aryl, heteroaryl, alkoxy or amino or a group which favours intracellular uptake or as labelling of a DNA probe or which on hybridisation interacts with the target nucleic acid, where if Z is OH, SH, CH3 or OC2H5, at least one of the groups X, Y, Y', V, W is not equal to OH or O, or R is not equal to H; process for their preparation and their use as inhibitors of gene expression, as probes for detecting nucleic acids and as aids in molecular biology.
-
-
-
-
-
-
-
-
-